Definium Therapeutics (DFTX) Exchange Rate Effect (2021 - 2026)
Definium Therapeutics' (DFTX) quarterly Exchange Rate Effect came in at $3000.0 in Q1 2026, up 125.0% year-on-year from $1333.3 in Q1 2025, and up 200.0% on a QoQ basis from $1000.0 in Q4 2025.
Definium Therapeutics (DFTX) Exchange Rate Effect (2021 - 2026) Analysis & Trends
Definium Therapeutics (DFTX) has 6 years of Exchange Rate Effect data on file, last reported at $3000.0 in Q1 2026.
- On a quarterly basis, Exchange Rate Effect rose 125.0% year-over-year to $3000.0 in Q1 2026; TTM through Mar 2026 was $8000.0, a 138.1% increase from a year earlier, with the FY2025 full-year figure at -$7000.0, up 76.67% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at $3000.0, up from $1000.0 in the prior quarter.
- Over the last five years, Exchange Rate Effect for DFTX reached as high as $57000.0 in Q2 2023 and fell as low as -$194000.0 in Q2 2022.
- Historically, Exchange Rate Effect has averaged -$15529.4 across 5 years, with a median of $1000.0 in 2024.
- Across the five-year window, Exchange Rate Effect slumped 240.0% in 2024 and jumped 2400.0% in 2025, its largest moves.
- Year by year, Exchange Rate Effect stood at $56000.0 in 2022, then tumbled by 144.64% to -$25000.0 in 2023, then surged by 104.0% to $1000.0 in 2024, then changed by 0.0% to $1000.0 in 2025, then jumped by 200.0% to $3000.0 in 2026.
- Per Business Quant data, the three most recent Exchange Rate Effect figures were $3000.0 in Q1 2026, $1000.0 in Q4 2025, and -$21000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Definium Therapeutics | 4.47 Bn | 4.47 Bn | - | 3,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,000.00 |
| Mar 31, 2026 | 3,000.00 |
| Dec 31, 2025 | 1,000.00 |
| Dec 31, 2025 | 1,000.00 |
| Sep 30, 2025 | -21,000.00 |
| Sep 30, 2025 | -21,000.00 |
| Jun 30, 2025 | 25,000.00 |
| Jun 30, 2025 | 25,000.00 |
| Mar 31, 2025 | -12,000.00 |
| Mar 31, 2025 | -12,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Sep 30, 2024 | -11,000.00 |
| Sep 30, 2024 | -11,000.00 |
| Jun 30, 2024 | 1,000.00 |
| Jun 30, 2024 | 1,000.00 |
| Mar 31, 2024 | -21,000.00 |
| Mar 31, 2024 | -21,000.00 |
| Dec 31, 2023 | -25,000.00 |
| Dec 31, 2023 | -25,000.00 |